{"DataElement":{"publicId":"6586591","version":"1","preferredName":"Choroid and Ciliary Body Uveal Melanoma AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for choroidal and ciliary body melanoma, using AJCC Ed. 8 criteria.","longName":"CCB_AJC8_DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6586427","version":"1","preferredName":"Choroid And Ciliary Body Uveal Melanoma Stage Grouping","preferredDefinition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens._A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6586235v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6586235","version":"1","preferredName":"Choroid And Ciliary Body Uveal Melanoma","preferredDefinition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens.:A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","longName":"C12344:C37912:C12345:C7712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid","conceptCode":"C12344","definition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ciliary Body","conceptCode":"C12345","definition":"Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB15681-4CE4-0958-E053-F662850A2AAD","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7CB14677-C728-0968-E053-F662850A4A2E","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9-6-19 TMT released per MC.; 12/10/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6586560","version":"1","preferredName":"Choroidal and Ciliary Body Melanoma American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of choroidal and ciliary body melanoma, following the rules of the TNM AJCC v8 classification system._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6586560v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Choroidal and Ciliary Body Melanoma AJCC v8","ValueMeaning":{"publicId":"6586562","version":"1","preferredName":"Stage IV Choroidal and Ciliary Body Melanoma AJCC v8","longName":"6586562","preferredDefinition":"Stage IV includes: (Any T, N1, M0); (Any T, Any N, M1a-c). N1: Regional lymph node metastasis or discrete tumor deposits in the orbit. M0: No distant metastasis. M1a: Distant metastasis, with the largest diameter of the largest metastasis measuring 3 cm or less. M1b: Distant metastasis, with the largest diameter of the largest metastasis measuring 3.1-8.0 cm. M1c: Distant metastasis, with the largest diameter of the largest metastasis measuring 8.1 cm or more.  (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Choroidal and Ciliary Body Melanoma AJCC v8","conceptCode":"C140668","definition":"Stage IV includes: (Any T, N1, M0); (Any T, Any N, M1a-c). N1: Regional lymph node metastasis or discrete tumor deposits in the orbit. M0: No distant metastasis. M1a: Distant metastasis, with the largest diameter of the largest metastasis measuring 3 cm or less. M1b: Distant metastasis, with the largest diameter of the largest metastasis measuring 3.1-8.0 cm. M1c: Distant metastasis, with the largest diameter of the largest metastasis measuring 8.1 cm or more.  (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFE4A0-8336-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBFE4A0-834F-7647-E053-F662850A3FAC","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8","ValueMeaning":{"publicId":"6586564","version":"1","preferredName":"Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8","longName":"6586564","preferredDefinition":"Stage IIIB includes: (T3d, N0, M0); (T4b-c, N0, M0). T3d: Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter.  T4b: Tumor size category 4 with ciliary body involvement. T4c: Tumor size category 4 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. N0: No regional lymph node metastasis. M0: No distant metastasis.  (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8","conceptCode":"C140666","definition":"Stage IIIB includes: (T3d, N0, M0); (T4b-c, N0, M0). T3d: Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter.  T4b: Tumor size category 4 with ciliary body involvement. T4c: Tumor size category 4 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. N0: No regional lymph node metastasis. M0: No distant metastasis.  (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFE4A0-835C-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBFE4A0-8375-7647-E053-F662850A3FAC","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8","ValueMeaning":{"publicId":"6586566","version":"1","preferredName":"Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8","longName":"6586566","preferredDefinition":"Stage IIIA includes: (T2c-d, N0, M0); (T3b-c, N0, M0); (T4a, N0, M0). T2c: Tumor size category 2 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T2d: Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T3b: Tumor size category 3 with ciliary body involvement. T3c: Tumor size category 3 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T4a: Tumor size category 4 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis.  (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8","conceptCode":"C140665","definition":"Stage IIIA includes: (T2c-d, N0, M0); (T3b-c, N0, M0); (T4a, N0, M0). T2c: Tumor size category 2 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T2d: Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T3b: Tumor size category 3 with ciliary body involvement. T3c: Tumor size category 3 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T4a: Tumor size category 4 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis.  (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFE4A0-8382-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBFE4A0-839B-7647-E053-F662850A3FAC","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8","ValueMeaning":{"publicId":"6586568","version":"1","preferredName":"Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8","longName":"6586568","preferredDefinition":"Stage IIB includes: (T2b, N0, M0); (T3a, N0, M0).  T2b: Tumor size category 2 with ciliary body involvement. T3a: Tumor size category 3 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8","conceptCode":"C140663","definition":"Stage IIB includes: (T2b, N0, M0); (T3a, N0, M0).  T2b: Tumor size category 2 with ciliary body involvement. T3a: Tumor size category 3 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFE4A0-83A8-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBFE4A0-83C1-7647-E053-F662850A3FAC","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8","ValueMeaning":{"publicId":"6586570","version":"1","preferredName":"Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8","longName":"6586570","preferredDefinition":"Stage IIA includes: (T1b-d, N0, M0); (T2a, N0, M0).  T1b: Tumor size category 1 with ciliary body involvement.  T1c: Tumor size category 1 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter.  T1d: Tumor size category 1 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T2a: Tumor size category 2 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8","conceptCode":"C140662","definition":"Stage IIA includes: (T1b-d, N0, M0); (T2a, N0, M0).  T1b: Tumor size category 1 with ciliary body involvement.  T1c: Tumor size category 1 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter.  T1d: Tumor size category 1 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T2a: Tumor size category 2 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFE4A0-83CE-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBFE4A0-83E7-7647-E053-F662850A3FAC","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Choroidal and Ciliary Body Melanoma AJCC v8","ValueMeaning":{"publicId":"6586572","version":"1","preferredName":"Stage I Choroidal and Ciliary Body Melanoma AJCC v8","longName":"6586572","preferredDefinition":"Stage I includes: T1a, N0, M0. T1a: Tumor size category 1 without ciliary body involvement and extraocular extension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Choroidal and Ciliary Body Melanoma AJCC v8","conceptCode":"C140660","definition":"Stage I includes: T1a, N0, M0. T1a: Tumor size category 1 without ciliary body involvement and extraocular extension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFE4A0-83F4-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBFE4A0-840D-7647-E053-F662850A3FAC","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8","ValueMeaning":{"publicId":"6920710","version":"1","preferredName":"Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8","longName":"6920710","preferredDefinition":"Stage IIIC includes: T4d-e, N0, M0. T4d: Tumor size category 4 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T4e: Any tumor size category with extraocular extension more than 5 mm in largest diameter. N0: No regional lymph node metastasis. M0: No distant metastasis.  (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8","conceptCode":"C140667","definition":"Stage IIIC includes: T4d-e, N0, M0. T4d: Tumor size category 4 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T4e: Any tumor size category with extraocular extension more than 5 mm in largest diameter. N0: No regional lymph node metastasis. M0: No distant metastasis.  (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91E6E7DC-D2F0-0ABF-E053-F662850A347E","latestVersionIndicator":"Yes","beginDate":"2019-09-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-09-06","modifiedBy":"ONEDATA","dateModified":"2019-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91E6E7DC-D309-0ABF-E053-F662850A347E","beginDate":"2019-09-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-09-06","modifiedBy":"ONEDATA","dateModified":"2019-09-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6586559","version":"1","preferredName":"Choroidal and Ciliary Body Melanoma by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of choroidal and ciliary body melanoma, following the rules of the TNM AJCC v8 classification system.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C140659:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroidal and Ciliary Body Melanoma by AJCC v8 Stage","conceptCode":"C140659","definition":"A term that refers to the staging of choroidal and ciliary body melanoma, following the rules of the TNM AJCC v8 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBFE4A0-8309-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7CBFE4A0-831A-7647-E053-F662850A3FAC","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9/6/19 TMT released per MC; added PV. 12/11/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6581919","version":"1","longName":"Uveal","context":"NCI Standards"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779574","version":"1","longName":"UVM Baseline","context":"OCCPR"}]}],"AlternateNames":[{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"},{"name":"CPTAC-BSLN-1","type":"Alternate Question Text","description":"Tumor Stage (Pathologic)","url":null,"context":"OCCPR"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7CBF1426-B62C-0B83-E053-F662850A829A","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"KNABLEJ","dateModified":"2020-05-13","changeDescription":"9-6-19 TMT released per MC.; 12/11/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}